Article info

Download PDFPDF

4CPS-106 Safety of adjuvant trastuzumab emtansina for residual invasive HER2-positive early breast cancer
Free

Authors

Citation

Martínez Pradeda A, Rabuñal Alvarez M, Busto Fernández F, et al
4CPS-106 Safety of adjuvant trastuzumab emtansina for residual invasive HER2-positive early breast cancer

Publication history

  • First published March 23, 2022.
Online issue publication 
April 22, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.